whether they can keep that thing rolling while big pharma has big money to spend >> avoiding the big arma and big money, what are the possible road blocks that you mentioned there? >> they can certainly grow as independent companies and they can commercialize themselves and with the availability of capital, it works two ways, gentlemen, sanofi has the capital, and yes, big pharma, but also as edwin pointed out, he has raised money on nasdaq. and it is possible to build companies themselves and become potentially the next amgen of europe >> thank you very much >>> now, brexit talks come back into focus later today a meeting of the eu general affairs council. this in turn will provide the commission with a formal mandate to initiate talks with the uk on a transition period after brexit but brexit sector davis has played down in the uk, on terms of that, speaking in middlebrook, mr. davis said he's confident they can reach an agreement at the march european council, let's take a listen >> immediate goal, we will reach an agreement on the implementation period. and because it's largely th

this is no privacy this is this is profit over people's lives people's eyes people's health and big pharma owns our government they've captured the regulators the media the politicians and maybe just maybe this is one of the reasons american kids we just found out are seventy percent more likely to die before adulthood than kids in other rich countries maybe they're dying because they're all jumping off a bridge when they realize donald trump is president and the o.b. one could no be your only hope candidate is oprah winfrey. the no other feel your. t.v. star. talks. which we've pretty soon the head of the food and drug administration will be charlie sheen. and the surgeon general will be yakking from animaniacs. point even a toddler probably thinks. the cold dark abyss of nonexistence sounds better than this. speaking of the cold dark abyss during the bombsite clone kids in baltimore schools were sitting in forty degree classrooms because the city wouldn't pay for heating repairs but it's not just baltimore the american society of civil engineers.

there is no privacy this is this is profit over people's lives people's eyes people's health and big pharma owns our government they've captured the regulators the media the politicians and maybe just maybe this is one of the reasons american kids we just found out are seventy percent more likely to die before adulthood than kids in other.

this is a travesty this is this is profit over people's lives people's eyes people's health and big pharma odes our government they've captured the regulators the media the politicians and maybe just maybe this is one of the reasons american kids we just found out are seventy percent more likely to die before adulthood than kids in other rich countries maybe they're dying because they're all jumping off a bridge when they realize donald trump is president and the o.b. one could no be your only hope candidate is oprah winfrey. on the other field. yes. he'd start. hawkster. which we've pretty soon the head of the food and drug administration will be charlie sheen. and the surgeon general will be yakking from animaniacs. point even a toddler probably thinks. the cold dark abyss of nonexistence sounds better than this. speaking of the cold dark abyss during the bombsite clone kids in baltimore schools were sitting in forty degree classrooms because the city wouldn't pay for heating repairs but it's not just baltimore the american society of civil engineers found that more than half of the nati

outlier orterally an would you make the same accusation of all big pharma? of big pharma would have to look in the mirror and justify their price increases and really struggle to do it in terms of improving value. erik: that is tim wentworth. of expresseo scripts. we are live from the jpmorgan health care conference in san francisco. many more interviews coming your way. schatzkeranks to erik in san francisco. i want to mention that at 2:30 eastern eric is going to be back. he will be speaking with the ceo of medicare and medicaid provider 17. aesident trump is hosting bipartisan meeting on immigration at the white house. headlines have been crossing and president saying that representative bob goodlatte from virginia will be submitted immigration bill in the next few days. he also talked about the need -- wall for aaw fairly good portion. new york times is reporting that president donald trump will attend the world economic forum. this is particularly interesting as the president would have run as the anti-davos man. this is bloomberg. ♪ vonnie: president t

philadelphia leaders believe this nightmare has been forced on them by big pharma the companies who make opioids and falsely marketed them as pain relief without at diction. >> the city currently in the grips of what can be termed as a public health nightmare. >> reporter: nightmare that's cost millions for police, first responders and treatment of the addicted. so the city has turn to the courts to get its money back. filing wednesday a 160 page lawsuit to match the size of the problem. >> today we're asking the companies that sell these drugs to stop pushing these drugs in philadelphia. and to start helping us clean up the problems they have caused. >> reporter: named are ten big drug makers like johnson & johnson, perdue pharma and endo health solutions and janson pharmaceuticals. they're accused of deceptive marketing and sale of prescription opioids. the city has linked with private law firms to do the heavy legal lifting in return for one third of any payout. >> i sell syringes to support my habit. this way i don't have to rob and steel or anything like that. >> reporter: back in f

barry was a pioneering drug tycoon eager to take on big pharma and his wife a patron to many charitiesway millions to causes. all that more horrific that they died in such a way. the children have launched an independent investigation of their own. they said that their preliminary findings are consistent with the police. >> reporter: the shermans had relations with prime ministers both past and present and it has left many shake even wondering by whom and why. paula newton, cnn. >>> you are watching "cnn newsroom." found in light. it makes us feel alive. it illuminates our world and connects us to each other. with transitions® adaptive lenses® you'll live the good light. they block uv rays. plus they help protect from harmful blue light. both indoors... and out. enjoy life more comfortably. enjoy life more richly. live the good light. find an eyecare professional at transitions.com we use so why do we pay touters thave a phone connected. when we're already paying for internet? shouldn't it all just be one thing? that's why xfinity mobile comes with your internet. you can get 5 lines of

but first, let's talk about new york city mayor bill de blasio taking on big pharma.s did he see youd to have the city sue the pharmaceutical companies because he wants to recover the $500 million in costs he says it cost new york fighting the opioid addiction crisis. allison gormly has the full story. allison, what do you got for us. >> new york city mayor bill deblass sy yo-yo announced new york city filed a lawsuit against multiple companies. accoring a press release the aim is to hold prescription opioid manufacturers and distribute accountable for their part in the city's ongoing deadly epidemic. the suit which named companies like johnson and jon and pharmaseeks to over a half billion dollars for future costs the city will n'dour combat this epidemic. >> who is getting away with bloody murder right now? it is a big approval rating suit call company. that is what is going on. the people who created the crisis are getting away with it. >> the release states that morning know, died in 2016 from opioid overdoses than homicides and car accidents combined. we spoke to

tutoring session apparently let's move on to a group that does respect the us dollar appropriately big pharma. company called spark therapeutics has found a cure for one of the causes of blindness it's huge news and it's still see one of the most expensive medicines ever sold eight hundred fifty thousand dollars nearly all the million dollars to see you again you know like if you if you take someone's kids hostage and demand. money everyone flips out right here on the evening news say divorce or change kiddies hostage writes big deal but if you take someone's vision hostage and demand the same amount of money then you pharmaceutical companies. and thank you. explain that to me let's split the difference how about you take somebodies kids vision hostage give me a million dollars or little timmy will never see is a birthday no i mean he'll never see his eighth birthday. this is no privacy this is this is profit over people's lives people on.

as we saw today legacy big pharma like eli lillys, even when headline was pretty good, i talked about the good ones, how about the bad ones, we sold some higher but it stung. yesterday i cautioned you not to soon this health care selloff was a buying opportunity but the ones that reported these numbers buy into this empire strikes back i love that you are getting a chance to buy my two favorites so far in 2018 which are abbvie and bio gen. ann in new york. >> caller: hi, jim, i am new to the stock market i have been learning a lot do you think nov artis >> among the i have not focused on it. let's go to umberto from new jersey. >> caller: i am looking to buy bristol mayers is it a good time to invest? >> i am not going to bless broad base drive my focus is on abbvie and bio gen. let's go to raymond in where my daughter is, oregon. >> caller: i want to find out if sell gene is taking it over. and i want to know if anything over -- or to wait until after the sale >> you have got cha-ching, cha-ching. the problem with -- abbvie and bio jen delivered fabulous numbers. i think you are gett

you have one of the best growth victories in big pharma. it has been widely technology. a lot of that future hinges on the success of to the city -- of trulicity. how confident are you? the outcome data it has demonstrated is good. dave: that is true. we have a cardiovascular study that we will have out late, this year. the outcome data itthe competito products in the class, one of them does have a cardiovascular claim. the weekly form does not have that in their labor -- in their label. they will have to repeat that to get the claim. we like our competitive position because we have a lot of momentum and ease-of-use. we know with the -- we know people with diabetes truckle with daily monitoring their glucose levels. this offers a once a week shot. you put the device to your skin and it goes. it is very effective medication. we expect continued growth. that is not the only part. we have a number of products coming including ultra-rapid route insulin -- ultra-rapid insulin. we welcome competition. i think it helps get the products to more patients. -- does that play to you

should be huge for the company i think more to come given how starved big pharma is for new drugs.eo of wynn resorts told us what to do with massive purchase of stocks toad you would blow away the numbers, he was right and boosted the stock. can't believe people doubted the man. i'm not deterred that they took a drop you will regret dumping the stock. boeing is my favorite name on this list. much as i like most of the winners from the s&p, their moves more ephemeral case in point, micron. commodity chip maker reported good quarter and stock barely budged. not good for the tech company. action is telling you something bad may be lurking around the corner they make flash memory and d rams, former peaked and latter seems unsustainably high south koreans adding new capacity sells -- turns out stock is overvalued unless flash gets better, a possibility, i mike micron has marked time after stellar 88% gain i prefer n video or broadcom sustainable, dr horton the stocks that must be sold when the fed starts tightening mortgage not gone up housing shortage harder to build and pretty hard to

having said that, also if you look at the growth for the values, the big pharma friend, the high evaluation stocks, that has gotten further apart, and you have to watch that. there is some to go. growth is the place to be in the environment at the end of the day. if you look at the ratio of historical -- in a historical context, you see it is roughly three standard deviations out. so it is relatively expensive, growth and obal strong support on the equities side, there is some leg to grow here. >> mark: thank you. we will be back in just a second. vonnie? vonnie: we will talk emerging markets and other asset classes as well. a reminder. you can catch all of our interviews on the bloomberg. you don't even have to turn on your tv. just type in the function tvgo. you can contact us there. on twitter, fog us. i am @vonnie quinn. this is bloomberg. bloomberg. vonnie: from new york city, i am vonnie quinn. mark: and i am mark barton. european market close in roughly 14 minutes. u.s. stocks rallying, the dollar rerebounding after the bank of america reported strong earnings. a quick question on bi

multiple subsectors from insurers to drugstore chains to big pharma painting the broader markets a deep shade of blood red. president loves to watch the stock market, not sure he's loving this first major sell-off of 2018 coming just as he gears up to deliver very first state of the union address to the american people, scheduled for six hours from now. we know that he is rehearsing for the big speech as we speak. no doubt ready to take a big victory lap as the job market, the stock market and tax reform have done great things so far for the country, but could today's sell-off inspire him or force him to make any last minute edits? >>> plus can he deliver a plea to both sides of the aisle in order to kick his 2018 economic agenda into full gear? fair and balanced. we'll hear from two congress members in leadership positions who will be front and center at the state of the union address tonight. >>> plus apple rocked to the core and charlie is about to break big news from washington, d.c. less than an hour to the closing bell. let's start the "countdown." . >>> we are just getting this b

berry the pioneering drug tycoon always eager to take on big pharma and his wife patron to several charities. they gave away tens of millions. the children have lauchbed an independent investigation of their own and in a statement to media said their preliminary findings are consistent with that of police. the shermans had close ties to prime ministers both past and present and they have shaken the political establishment with many who could have wanted to see them dead and why. >> lt, paula, thank you. >>> so, it's been quite a week of major developments in the russia investigation. democrats now looking for a way to protect the man behind that investigation. >>> how the president's attempt to fire robert mueller may backfire. >>> plus, this year's flu season is on track to be one of the worst in nearly a decade. the cdc says still many more weeks to come. what you can do to stay protected. >>> also, the president following through on a campaign promise. why his decision has solar panel operators pretty concerned right now. >> yeah, definitely is nerve wracking. you're trying to keep your b

not only is it uniquely addictive and synthetic and shipped from big pharma suppliers, but you have overprescribings an aspect we never had to deal with with more elicit drugs. the urgency is there. we'll stay on it for you, senator. >> let me say this, chris. first of all, when you talked about how drugs are coming, fentanyl, a deadly drug, comes mostly through the mail. security, we talk about walls. we need ever thing. we need technology, drones, new agents, border patrol. we also need dock patrol where it comes through our ports. we need high-speed boats to intercept. we're talking about all of this. when you hear someone talk about just the wall, there's a lot more than just the wall. >> senator when you're talking opioids, your argument does not suck. i will tell senator collins to spare you the talking stick. >> thank you, chris. >> i can't get enough of the stick. >> i'm so glad she shod it to us. >> i believe they were figin with the stick. >> i would say let's go shot for shot with the stick. whoever wins, they get what they want. >> whereas i believe somebody could just drop it or not ca

and that's exec we were farm i -- that is exactly what big pharma did with $150 million in ad buys. they supported the passage of obamacare because they knew it would not touch them. this is at a time when prescription drug prices in this country are at an all-time high, in fact, they are one of the major drivers of health care costs in america. so even if you take a moment like that, where you have the african-american president first elected, democrats are running the house, democrats are running the senate, they have this big dream of getting health care done, something that harry truman talked about and couldn't make happen, bill clinton and hillary clinton talked about and make happen, finally bakr obama -- barack obama tries to do it and the first thing they do is exempt one big industry because they cannot tackle both at the same time. one would argue that they did not really tackle the insurance industry either because insurance company stocks have nearly doubled since obamacare became law. when you talk about the environment. you know bill mckibben, the guy , who started 35

big pharma and biotech have a lot of cash to spend from gilead and amgen to pfizer and merck.aird research breaking out overseas versus u.s. cash in light of the tax overhaul here many signaled greater spending many investors expect and hope more deals who are the most likely targets? rbc took a survey last month and the results fall into the pattern we see frequently in biotech deals. companies that make drugs for cancer it could mean $2 billion and $10 billion. there is clovis oncology, kooma biotech, blue bird bio, a cancer and rare diseases and novexis with a focus on rare diseases. a lot of speculation going on in biotech. people are hoping that 2018 is a big dearly year. >> also, meg, just on your beat, there had been some reports that there would be interruptions to flu monitoring you're saying not true >> no. it sounds like the flu is going to continue the federal flu monitoring the reports getting from states and counties there was some concern as the severe flu season goes on we wouldn't have the cdc monitoring it but they are continuing with the activities even as o

lemonis: because pot is still illegal under federal law, big pharma, tobacco, and other giants -- they'reon the sidelines... for now. adam: you don't have many people competing. it's the most inefficient market of our lifetime. lemonis: because people see the risk of the federal government not really allowing it, and wondering if they're going to flip flop. adam: i welcome the perception of that risk because it allows me to run as far and as fast as i can. lemonis: i thought adam was a very smart guy, very sophisticated. he understands his business. i would've never imagined that the retailing of marijuana would ever be this slick, this well-merchandised, and this lucrative. prior to going into the store, i would've never contemplated investing in this concept. but after seeing the frozen goods, the beverages, the consumerables, this is a real business -- a real business with a real retail footprint. you may not like it morally, but you definitely have to pay attention to it. up next, chasing their dream one edible at a time. if this doesn't work, you've lost the money and you have no inc

lieutenant governor: well, scott, you know big pharma is a multi-billion dollar industry. o you think medical grants?get big from big pharma, that is the root of the problem. pharmacist and i fill prescriptions, i'm in the business, but i will tell you overmedicated. we need to go back to natural remedies, we need to go back to our lifestyle as society, we're overmedicated, we used to instant results, not willing to change our lifestyle, what we eat watch to get healthy. you are right, we need to get and to natural remedies lifestyle changes and prescription medicine as a or e, whether opioids anything else need to be last resort and far too often it is first resort. that up, for bringing scott. eing from anderson, we're neighbors, good to talk to you on c-span. ost: from south carolina, nurey, michael, you are on. michael.ood morning, caller: i'll bet mr. bryant nurey is.w where go, tigers. guest: i do. yes, sir, to that end, r. bryant, sounds like if you and i sat down we might be able to get along. guest: i can get along with anybody. of the i'm one constituents who has

disruption of medical companies, big-cap pharma this is a big -- it's going to -- >>> for more on theade let's bring in our pot master, tim seemo? seymour hey, tim >> system my new moniker >> you're in ethereum and pot stocks, but fresh money white now, what is a better bet? >> i think value way iist i thi they see are valuations. i'm not going to tell you, if you look at canopy or aurora or gw pharma, they're not cheap, but in some case they haven't even begun to price in efficacy on a lot of the pain relief. whether it's epps lensy or industries that are starting to find application for this, that's the story here. it's not to me all that recreational in i think the legalization has been a catalyst, but the medical side has been a about ig de. the top four names make up 30, 40 percent, those names, you know, they are four, five, 6 billion companies, right now that's one way to get good exposure. >> when you're looking at the individual stocks, tim, is it important that these stocks are based or much of their business is in canada versus the united stat states. >>> my view is if you

the idea that big pharma lighting committed fraud is a part of the book and part of the problem. they're punished but we need to make sure people cannot. some of it could be state law. i continue to become more more alarmed that our profession is part of the problem. we've tried to fix it. we monitor and see if they're seeking different doctors we have gotten rid of bad doctors, the pill mills are no longer in kentucky. yet, we have a county in the mountains of 21000 people. last year 2.8 million dose of hydrocodone. everybody knows it's a problem. and it was worse last year. they prescribe more. it's an 11% increase. when we look at what we do we have to think about how we spend it and what we do. we want people to have healthcare so weeks been medicaid. you can have an overlay of the hair when an opiate problem is related to poverty and healthcare expansion. pay $3 a month and you can get it trade it. we have to figure out more rules. the hard part is the chronic. if i'm your physician and you been coming to me for low back pain that i get you off of it? we all know the knowled

big pharma saying we won't even sell you what you need to survive so we can support the companies we are related to. the impact is it guts our downtown. we don't have the small business downtown that has been the heart of so much of america for so long. this is again loneliness is a lot of sources, but commercial life as well as civic life has always been a way in which we come together, checking on someone's health, check in on suzy who has not been seen for two weeks and one of the essential way so i think we have forgotten the importance of antitrust, not just to take on these big guys who are stealing our tax dollars, but also to support a thriving small business community, which is the heart of our social community. does that make more sense? >> sure suzanne, i've been concerned personally with the state of the news media and frankly the frankly-- news literacy in the country for some time. talk more if you would about what can be done to allow the ordinary american to find their way through the thickets of my asthma, of true, false, some made up. >> on budget last because i do

big pharma kicks off with j & j tomorrow and ahead of our report, ge shares is getting downgraded byrica, larry lynch. stock is down at 8%. celgene is showing out 9 billion to june know therapeutics. allowing celgene to stay at the forefront at cellular therapy. check out the come back of online travelers after a disappointing third quarter season in case you were wondering, who owns bitcoin, according to this new global chain business count, shows it is millennial non white males own it because it is a growth investment and others say to avoid business -- keep an eye on central bank. bank of japan results out tomorrow ecp is on tap on thursday. >> see seema mody is on the floor lets get to rick santelli. >> you see the chart hovering one base above of what had been a high yield for quite a while from last march. look at boone, getting close to 60 base point but not touching it last time the bund settles of 60 and ironically of just one session that was around mid july 2017 the difference between r 10s and european 10s is hovering a little over 2% looks like it wants to break out a l

he founded the generic drug company apotex, with a lot of companies in the big pharma world as well asawsuits against him or the company at the time of their death. he had private investigators working for him, against him it was a very different life that they were leading they were selling their house, so now police are combing through the lawsuits, the suspects it was not a forced entry. it was something they knew this case just gets deeper and darker every day >> robert, thank you very much >> thank you very much >>> newark, new jersey making the list of top 20 lists for amazon now it has to make the pitch to be the one joining us is scott cohn he's live in newark with the former mayor and current senator cory booker. take it away, scott. >> that's right, cory booker was the mac -- mayor of new york, new jersey. >> newark, not new york. >> are we looking at another government shutdown next week? >> i certainly hope not. everyone knows there's a why bipartisan pathway forward to make sure we deal with immigration, which is probably one of the greatest economic opportunities that our

out and buying companies i think you're going to see more of the large cap biotech companies and big pharma companies do acquisitions with $150 billion to $200 billion in cash coming back to the u.s. to deploy i think you'll see more of these deals play out the second thing, as it relates to bluebird, although the stock is trading nicely up today, is while they might go out and buy that partner, and i can appreciate the investors think that, there's certainly a whole host of other companies that they could do. so i think with buy of juno is a positive that adds to the pipeline. bluebird, a potential, although i wouldn't say a high potential, and third is a lot more cancer and neurology deals to follow. >> are all the hopes riding on the one treatment? we saw what happened with j-car 15 when the company had to scuttle it almost a year ago now. >> look, in that timeframe, juno has bounced back they have shown great data at the ash conference just a couple months ago the stock reacted very well. seemed to be a lot more on the path to possibly getting approved in about a year so juno has not on

the idea that big pharma lied and committed fraud is part of the book and part of the problem.hey were punished but we need to make sure that people cannot lie and that is fraud and it is punished and it is preempted in some way. some of that to be federal and simply state law. as a physician, i continue to become more and more alarmed by our profession being part of the problem. try to fix this. in kentucky we monitor. you can type into that computer if patients need to find out if they are seeking different doctors. have they gotten opioids somewhere else two days before? we have come to the bank doctors. the bed doctors south of portsmith. they are mostly gone. the pill mills are no longer in kentucky and yet, we have a concept of the mountains that has 21,000 people. last year, said 2.8 million doses of hydrocodone and oxycodone. this was after all of the stuff. so everyone knows this is a problem.everyone knows more people are dying from car accident that is a horrible problem. and it was were/strings county pieces medicaid expansion and has an 11 percent increase. when we

. >> we will continue to monitor his actions. .here he is arriving big leader in pharma drugs. ugs are coming off of patent protection. , take it away. daniel, you are the health care conference. there is a lot of anxiety over the future of your cancer franchise. >> this is an exciting time for cancer care in general. than sixad more medicines in the last 10 years. most of those in the cancer field. cancer immunotherapy is making a big breakthrough. we have patience with kidney cancer. >> why is it that people see about the drugs coming off patents. are andwhere you others, the growing competitive threat, there are a number of other things i could go through. you talk a positive gain but investors don't see it in the same way. >> it is a natural business dynamic him you have a certain patent life, and you have competition. we fuel our pipeline and our portfolio. this is why i am excited. producing in the field of cancer but also outside of cancer. we showed a significant benefit for patients. overall in cancer and outside of cancer our pipeline is producing at the same time. >>

the idea that big pharma lied and committed fraud is part of the book and part of the problem.they were punished but we need to make sure that people cannot lie and that is fraud and it is punished and it is preempted in some way. some of that to be federal and simply state law. as a physician, i continue to become more and more alarmed by our profession being part of the problem. try to fix this. in kentucky we monitor. you can type into that computer if patients need to find out if they are seeking different doctors. have they gotten opioids somewhere else two days before? we have come to the bank doctors. the bed doctors south of portsmith. they are mostly gone. the pill mills are no longer in kentucky and yet, we have a concept of the mountains that has 21,000 people. last year, said 2.8 million doses of hydrocodone and oxycodone. this was after all of the stuff. so everyone knows this is a problem.everyone knows more people are dying from car accident that is a horrible problem. and it was were/strings county pieces medicaid expansion and has an 11 percent increase. when w

as i read the book in which i think what we do better or change, the idea that big pharma lied and committed fraud is a part of the book and a part of the problem. they were punished but we need to make sure that people cannot lie and that it is wrought and punished and it is preempted. some of it to be federal or state law. as a physician i continue to become more and more alarmed that are professionals part of the problem. and we've tried to fix it. in kentucky we done a lot of things. we monitor. you can type into the computer patients name and find out if you're seeking different doctors, , have gotten opioids summerhouse two days before. we've got rid of the bad doctors, the doctors you mention south of fort smith. they are mostly gone. the pill mills are no longer in kentucky, and yet when the kid up in the mountains that is 21,000 people. last year they had 2.8 2.8 miln doses of hydrocodone and oxycodone. this is after all the stuff it's all the stuff and we knows it's a problem cut of windows more people are dying that are dying from car accident, that it is horrible problem and it w

is idea that big pharma lied a part of the book and a part of the problem. they were punished, but we need to make sure people cannot lie. some of that can be federal, some of that can be state law. i continued to become more and more alarmed that our profession was part of the problem. we have tried to fix it. in kentucky we have done a lot of things -- you can type in and find out if they're seeking different doctors. we have gotten rid of the bad doctors, the doctors you mentioned. they are mostly gone. are no longer in kentucky. we have a county in kentucky that has 21,000 people. last year they had 2.8 million doses of oxycodone. everybody knows it is a problem. more people are dying that are dying from car accidents. it was worse last year this county. they prescribed more. since medicaid expansion, it is an 11% increase. when we look at what we do, let's say, let's have a marshall plan. we need to think about how we spend the money and what we do. we wanted more people have health care so we expanded medicaid. if you look at the expansion of medicaid

are you expect in companies to get acquired not that big pharma could be on the lookout even more foriotech deals? >> we know that far may need the innovation in the need to fill their pipelines. we do know that there's going to be entranced in mma and some of their companies acquired good and it will be an exciting year. dagen: it certainly sounds like it. thanks for joining us. abbie celniker joining us there. hard rock ventures. this morning a digital assistants you wearing your face. that's the plan for amazon from alexei. check out amazon shares over the last four months. the dark comedy ladybird wins big, but the most buzz for the moment started the red carpet has hollywood shows the need to moment as they break down the most noteworthy on and offstage moments. that is next. ♪ it's time for sleep number's 'lowest prices of the season' on the only bed that adjusts on both sides to your ideal comfort, your sleep number setting. and snoring? does your bed do that? it's the lowest prices of the season on the queen c4 mattress with adjustable comfort on both sides. now only $1199, sa

given the conversation from a florida congressman ron desantis is that this big pharma chief of staff under bill clinton and then bacardi associates max mclarty is here. fox news strategic and news strategic analyst jackie messier as those former food network host and uncle jack's steakhouse owner, will lead the goal. stay with us. big broker in the head. take it off here and that is president trump sturdiness with the jampacked agenda. touching down at the white house last night after reading in the new year in palm beach, florida where he reflected on the accomplishment while also looking forward to the future. >> we will have a great year come a fantastic 28 teams. off to a very good start with the great tax cut with an warrant getting rid of the individual mandate, which is very unpopular as you know. but we are going to have a tremendous year. the stock market is going to continue to go up. companies will continue to come into the country and they are doing it now. soon to be a record for. maria: congress to turn with a hefty to-do list included funding the government to avoid a

as i read through the book, and we try to think what can we do better or change, the idea that big pharma lied and committed fraud is a part of the book and a part of the problem. they were punished, but we need to make sure that people cannot lie and that it is fraud and it's punished, and it's preempted in some way. some of that could be federal, some could be state law. as a physician, i continue to become more and more alarmed that, you know, our profession is part of the problem. and we have tried to fix it. in kentucky, we have done a lot of things. we monitor, you can type into the computer patient's name, find out if they're seeking different doctors, have they gotten opioids somewhere else two days before. we have gotten rid of the bad doctors, the doctors you mention south of portsmouth, you know, mostly gone. the pill mills are no longer in kentucky, and yet, we have a county up in the mountains that has 21,000 people. last year, they had 2.8 million doses of hydrocodone and oxycodo oxycodone. this is after all the stuff. all the stuff, everybody knows it's a problem. everybody

big way. there are some pharma companies who also dropped. big picture we saw selling across the board. had been down 411. with the dow down 362 points. melissa, safe? melissa: nicole, thank you. david: bring in the market panel today. james freeman, "wall street journal," fox news contributor and kevin kelly from benchmark investments. james, i will begin with you and bring in a big conspiracy theory talked about a lot, that jeff bezos and warren buffett wanted to sour the president's first state of the union and therefore they announced this deal, knowing that it would tank the insurance stocks and bring down the market. what do you think about that conspiracy theory? >> i am not going to endorse that. this is an interesting announcement. we haven't seen a lot of details , but buffett and bezos, maybe they get together, maybe they bring in democratic governor and start applying to washington for waivers from obamacare? probably they could get pretty good media coverage on that kind of venture. david: i'm sure they would. >> might be good for the country if they start experimenting, pu

lemonis: because pot is still illegal under federal law, big pharma, tobacco, and other giants -- they'rethe sidelines... for now. adam: you don't have many people competing. it's the most inefficient market of our lifetime. lemonis: because people see the risk of the federal government not really allowing it, and wondering if they're going to flip flop. adam: i welcome the perception of that risk because it allows me to run as far and as fast as i can. lemonis: i thought adam was a very smart guy, very sophisticated. he understands his business. i would've never imagined that the retailing of marijuana would ever be this slick, this well-merchandised, and this lucrative. prior to going into the store, i would've never contemplated investing in this concept. but after seeing the frozen goods, the beverages, the consumerables, this is a real business -- a real business with a real retail footprint. you may not like it morally, but you definitely have to pay attention to it. up next, chasing their dream one edible at a time. if this doesn't work, you've lost the money and you have no income

. >> reporter: he points to big phar pharma's influence in decisionmaking, including a meeting in 2002vise them had ties to the industry. >> they could have changed the rules so we wouldn't get a steady stream of new opioids hitting the market, each one pouring fuel on a fire. >> reporter: as the opioid epidemic ravaged the country, in 2014, the fda approved another powerful opioid called zohydro. this time, over the objections of a panel of experts, who strovoted 11-2 against it. >> why did the fda continue to allow more of the opiate drugs on the market. >> reporter: opioid painkillers were flooding his state. >> they were everywhere. 1 community had 9 million pills coming into it. >> reporter: determined to tighten controls on prescriptions, he headed to the fda. >> i go up and i testified before their advisory committee, should have been a shlam-dunk, right? >> reporter: it wasn't. it took a year for the fda to take action. and a year after that for a policy to be in effect. the following year, a billion less pills were described. >> there is no bona fide justifiable reason to allo

big deal. potentially a good fit with our business. but we would only do it if we still have capital to invest as we deem appropriate. pharmaur number one priority. eric: what about divestitures? you are at least evaluating options. david: we did a big strategic review of the pharma portfolios. there is one or two areas that we have decided to do prioritize -- to deprioritize. we have really been the leader. that will not be an outright investment that we think there probably is a different sort of partner that really focuses and prioritizes in that area. more of a partnership arrangement. prioritized. that's true. eric: you mentioned am a, your new -- emma, your new ceo. what has changed out of your leadership? david: some things have not changed. she is very much supportive of three businesses. spends a lot of time having a detailed look at gs k, really reinforced our values that are important to the vast majority across the world. on is extremely focused performance, and she has tightened up how we operate the matrices, accountability, decision-making rights and brought a lot of some of the consumer health care's discipl

the pharma and health care names taking big hits. health care sector down more than 1%.eg terrell is here with more. there was nothing new really in what he said he said similar things before, but the setting and the emphasis did feel different. >> certainly big emphasis last night. a lot of names are down significa significantly. you can see eli lilly getting hit hard there other names under pressure incollidii including gillead and amgen. it's not the first time trump slammed the drug industry for prices from saying the industry is, quoting getting away with murder last january to attacking merck for pricing after ceo ken frazier stepped down from a presidential council over the summer in august many folks i have been talking with including last night during the speech thought trump's rhetoric started to lose effect since he's been calling wolf all year saying he'd bring down drug prices but not doing anything about it today warnings about complacency saying it ranks too high to be forgotten. we believe both dems and republicans will keep the issue alive in 2018. he ex

pharma in 2015 and buying ariad last year all at multibillion dollar valuations. many question whether there's been enough time to digest the tax overall for bigompanies to trigger this and many report q4 results early. three stocks to watch, celgene, a tough fourth quarter, something of a bellwether for all and drove more generalist investors out of the space and also, jpmorgan announced in previous years and the stock under pressure down 14% in the last year. and regenreon, reports at the conference and ceo schleifer on. a space you won't want to miss. >> thanks, meg. >>> and biotech stocks among top performers should you keep betting on them in the new year? carter is at the plaza to break it down. >> i like them keep betting on them in the new year look at the charts see if it makes sense when we do since inception, ibb we know when you have dynamic groundbreaking, life-changing product, you can have dynamic groundbreaking life-changing results. ibb doubled the performance of the general equity market since launch a lot of different companies but the point is as a theme as a bet as an aggregate a place you want to be long term. the issue,

got people excited again and we have the big health care conference that jpmorgan holds next week and everyone is deals, etc. you will continue to see cherub pharma, but in terms of wholesale m&a, that will still end up being dependent on assets and specific needs of the pharma companies. science coming more in focus. sam: entirely. volatility is so much that two weeks later, what i write is irrelevant. whattrength of the euro is we need to keep an eye on. 1.22 ther is back at euro and it is one we need to think about when it comes to the euro reporting companies. it is important for the u.s. as they suffered from the strength of the dollar, now it has weakened and helped them. we saw that in q3 and i expected in q4 too. guy: we will look forward to that jpmorgan conference. senior pharmaceutical analyst sam fazeli, thank you. next, the euro in 2018. can we get used to an even stronger single currency? we go to berlin and get a take. that is next. this is bloomberg. ♪ ♪ 8:52 in london. we have had a whole range of data out this morning and the pmi, surveys, soft data, are generally below where we were anticipating they would be. we have had that

big minus signs here. >> now we're talking about stocks the stock market rally about to become the greatest of all-time? >>> and a major pharmany is raising the white flag in its fight against alzheimer's and parkinson's. i cannot believe this story. we'll get to that later. >>> let's get to the top story, though, brian was talking about it, apple and this debate spawned by investors who are urging

big chains we work with we also sell directly. but what i would encourage almost anybody, whether it be in pharma, med device, we should be a actingamazon is getting into our business. frankly, we have to create a crisis we have to make sure we're always competitive, always thinking about how to be more effective, how to be more efficient, so we're thinking that way across all of our different businesses >> would you welcome amazon in are you talking with them about their role >> if it leads to better customer satisfaction, if it leads to greater transparency, for example, around pricing, if it leads to ultimately better outcomes for patients, of course, we welcome them in >> any conversations happening >> i won't go down that road right now, but i think having healthy competition can be a positive thing but you know, we always have to keep the patient, the consumer in mind. >> i want to ask you more broadly about the political environment right now. and a big debate going on outside this conference is the immigration debate and what's going on with daca and d.r.e.a.m.ers. some of my colleagues this morning interviewed a j & j emp

big minus signs here. >> now we're talking about stocks the stock market rally about to become the greatest of all-time? >>> and a major pharma company is raising the white flag in its fight against alzheimer's and parkinson's. i cannot believe this story. we'll get to that later. >>> let's get to the top story, though, brian was talking about it, apple and this debate spawned by investors who are urging apple to consider the impact that its products have on smartphone addiction in children cnbc's leslie picker has more on this story for us. leslie >> hey, bill, that's right, it's a twist on activist investing. jana and california state teachers' retirement system, sending a letter over the weekend to apple's board pushing for changes there. in the letter, they say that apple's ubiquity has created unintended negative consequences for children, particularly when it comes to their physical and mental health. they want apple to form a committee to study this issue and add more restrictions for younger users. apple already provides tools that allow parents to restrict what their kids do on their phones, but jana and calsters bel